verified SJR 1,833 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · BioMed Central Ltd

workspace_premium Q1 — Molecular Biology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Clinical Epigenetics

Clinical Epigenetics is a journal indexed in SJR in Molecular Biology and Developmental Biology with an H index of 86. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2590 €. The scope of the journal is focused on genetic processes, epigenetic therapy. It has an SJR impact factor of 1,833 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,833.

Clinical Epigenetics focuses its scope in these topics and keywords: methylation, dna, hoxa, diabetes, mellitus, promoters, predicts, epigenomic, transporter, myelogenous, ...

ISSN: 1868-7075

Publisher: BioMed Central Ltd

Category: Molecular Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,833 Q1

H-index 86

Acceptance rate pie_chart

28% Selective

Source Acceptance_Rate

Time to publication hourglass_top

12 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

2.590 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,833

H-index

Docs (year)

185

Docs 3y

609

Total refs

10881

Cites 3y

3081

Citable 3y

605

Cites/Doc 2y

4.38

Ref/Doc

58.82

Immediate OA

2590 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions - benign adenomas and inflammatory bowel disease

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging

DNA methylation levels are highly correlated between pooled samples and averaged values when analysed using the Infinium HumanMethylation450 BeadChip array

DNA hydroxymethylation age of human blood determined by capillary hydrophilic-interaction liquid chromatography/mass spectrometry

Disagreement between two common biomarkers of global DNA methylation

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways

Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE-/- mice

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites

Correction to: Prediction of smoking by multiplex bisulfite PCR with long amplicons considering allele-specific effects on DNA methylation

Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients

Circulating tumour DNA for monitoring colorectal cancer - a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection

SHOW MORE ARTICLES

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer

"Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma"

Cancer: evolutionary, genetic and epigenetic aspects

Can metabolic plasticity be a cause for cancer? Warburg-Waddington legacy revisited

Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC)

Assessment of global DNA methylation in the first trimester fetal tissues exposed to maternal cigarette smoking

An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome

Allelic variation in the canine Cox-2 promoter causes hypermethylation of the canine Cox-2 promoter in clinical cases of renal dysplasia

ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients

A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours

A combined epigenome- and transcriptome-wide association study of the oral masticatory mucosa assigns CYP1B1 a central role for epithelial health in smokers

5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer

FAQs

Clinical Epigenetics has an SJR of 1,833 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2590 EUR.

The acceptance rate recorded for Clinical Epigenetics is 28%.

Clinical Epigenetics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Clinical Epigenetics?

What is the APC / publication cost?

What is the acceptance rate?